Ad tech stocks
CDLX1.10▼ -9.84%18608.57▼ -8.39%0700348.40▼ -6.55%IHRT0.52▼ -5.71%AZRN0.60▲ +4.90%SNOW293.12▲ +4.83%SCOR2.70▼ -4.17%DSP11.78▲ +3.79%CPNG14.76▲ +3.36%ZETA35.06▲ +3.24%SST0.70▼ -3.03%BABA86.90▲ +3.00%GOOGL290.68▲ +2.92%SPOT590.43▼ -2.54%APPS6.73▲ +2.36%IBTA54.24▼ -2.32%LFTO24.54▲ +2.23%MNTN4.70▲ +2.03%OUT32.20▼ -1.96%INUV0.27▲ +1.89%OMC86.55▼ -1.84%TEAD0.14▲ +1.64%24331413.00▲ +1.62%WPP401.10▼ -1.55%47511374.50▲ +1.51%TRU74.70▼ -1.48%NEXN9.44▼ -1.41%PUBM20.96▲ +1.40%035420168300.00▼ -1.17%AAPL348.87▼ -1.02%META622.18▲ +0.94%CRTO18.61▼ -0.91%DEC27.44▲ +0.81%PUB100.65▼ -0.79%MGNI27.91▲ +0.74%RAMP38.50▲ +0.71%SFOR35.25▼ -0.70%SAX36.86▼ -0.70%STGW10.88▼ -0.64%APP393.34▲ +0.62%SIRI32.02▼ -0.62%U49.26▲ +0.60%4755609.40▼ -0.55%RDDT94.61▲ +0.55%SNAP5.47▲ +0.55%TBLA2.03▲ +0.50%PERI11.06▼ -0.36%HAVAS17.90▲ +0.28%VER8.86▲ +0.23%BIDU69.06▼ -0.22%NFLX59.95▲ +0.22%CART58.56▼ -0.17%PINS17.67▼ -0.11%ROKU160.52▲ +0.09%DV13.56▲ +0.04%TTD15.52▲ +0.03%CCO2.43▲ 0.00%43243786.00▲ 0.00%ILLM0.52▲ 0.00%PSKY9.78▲ 0.00%WBD30.95▲ 0.00%
PolicyNorth America

Ultra faces regulatory complaints over 'Zyn and Adderall' ad's health claims

· 5h ago · Originally reported by PPC Land

Complaints filed November 17 with the FTC, FDA and New York authorities allege that Ultra's 'Zyn and Adderall' video, which has drawn around 32 million views, contains over 100 unverified health claims and targets minors. It is unclear whether any agency will open an investigation.

Why it matters

If regulators act, the case could test how health claims in social video ads are policed and raise compliance risks for brands relying on viral creator-style content.

Explain it like I’m new here

It's like a kid making big claims on a school video — the principals (the FTC and FDA) were handed a note asking them to check whether the claims are true.

Read the original at PPC Land

Terms in this story

Go deeper

Related stories